Sydbank A/S
XBER:TM2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sydbank A/S
XBER:TM2
|
DK |
|
M
|
Mitra Adiperkasa Tbk PT
F:QGI
|
ID |
|
Basler AG
F:BSL
|
DE |
|
S
|
Sumitomo Pharma Co Ltd
XMUN:DPM
|
JP |
|
S
|
Sumitomo Pharma Co Ltd
XBER:DPM
|
JP |
|
Kasumigaseki Capital Co Ltd
F:H0A
|
JP |
|
Hydro One Ltd
TSX:H
|
CA |
|
T
|
Titan International Inc
F:TZ4
|
US |
|
E
|
Eris Lifesciences Ltd
BSE:540596
|
IN |
|
Carel Industries SpA
F:CIG
|
IT |
Wall St Price Targets
TM2 Price Targets Summary
Sydbank A/S
According to Wall Street analysts, the average 1-year price target for
TM2 is 92.27 EUR with a low forecast of 87.02 EUR and a high forecast of 100.68 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TM2's stock price target?
Price Target
92.27
EUR
According to Wall Street analysts, the average 1-year price target for
TM2 is 92.27 EUR with a low forecast of 87.02 EUR and a high forecast of 100.68 EUR.